Medtronic PLC
MDT
Closed
$92.70
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Key stats
Open
$92.13
Volume
7.50M
Market cap
$119.49B
Prev. close
$93.35
Impl / hst vl
-
Open interest
$0.00
$91.73
Day’s Range
$93.55
$73.31
52W Range
$105.50
Valuation
50
Valuation score
Fairly Valued
P/E
24.25
P/S
3.20
P/B
2.35
Current ratio
2.13
Debt / Equity
0.57
ROE
9.85%
Gross margin
66.13%
Income growth
8.84%
FCF growth
-9.22
Jul
17
Dividends
The last payment date was Jul 17, 2026
Div. per Share
$0.72
Div. Yield
0.77%
Payout Ratio
75.78%
Div. Growth YoY
1.41%
Analysts estimates
Consensus rating
Buy
The average rating from top 12 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$100.80
The top 28 analysts forecasts that 12-month price may increase by 8.74%, with a low of $78.78 and a high of $127.05
$78.78
Low
$100.80
Avg
$127.05
High
Current price
Earnings
Q2 ‘26 revenue
$9.81B
Q2 ‘26 net income
$1.24B
Revenue
Net income
Previous EPS
$1.36
Estimate EPS
$1.35
Actual EPS
Estimate EPS
Discover more Shariah-compliant stocks
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply